BREAKING NEWS: The FDA has postponed the Advisory Committee meeting for the first-ever application to move a progestin-only birth control pill over the counter in the United States, which was originally scheduled for November 18. Read Ibis's statement here and continue to check our Action Center for updates.

Envisioning a future where birth control pills are available over the counter in the United States, fully covered by insurance, priced affordably, and accessible to people of all ages, identities, and backgrounds.